影响爱尔兰研究者发起试验启动因素调查
该研究分两阶段调查爱尔兰研究者发起试验启动障碍:第一阶段问卷44名研究者,第二阶段半结构化访谈9名2018年爱尔兰健康研究委员会确证性干预可行性奖获得者。合同与伦理审批被列为主要问题,场地识别与激活、方案开发时间、统计与数据管理专业人员可及性亦构成障碍。
要点
- 合同与伦理审批延迟被视为试验启动的主要障碍。
- 场地识别与激活在部分案例中存在问题。
- 统计与数据管理专业人员的可及性不足,尤其影响小型试验。
核心结论
- 多个因素影响爱尔兰试验的启动与推进,合同与伦理审批延迟被视为主要障碍。
研究设计与样本
- 两阶段设计:第一阶段问卷44名爱尔兰研究者;第二阶段对9名2018年爱尔兰健康研究委员会确证性干预可行性奖获得者进行半结构化访谈。
主要发现
- 合同与伦理审批被引用为主要问题。
- 场地识别与激活在部分案例中存在问题。
- 受访者报告难以获得方案开发的专门时间。
- 统计学家与数据管理员等熟练人员可及性被视为问题,尤其对小型试验。
临床怎么用
- 建议在伦理与监管事务领域提供专科支持,并提升统计与数据管理专业人员的可及性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In common with many countries, Ireland has seen an increasing trend in the number of clinical trials conducted over the past few years. Yet, as elsewhere, trialists in Ireland face several problems and barriers in the starting-up of clinical trials. These barriers impede trial activity significantly, with consequent impacts on patient care. It is critical to understand these issues, to develop approaches to facilitate trial start up. This study identifies the challenges in conducting clinical trials in Ireland and specifically the contractual, ethical, logistical, and regulatory barriers that hinder the start-up of investigator-led trials in Ireland. METHODS: Data for this study were collected in two stages. In the first stage, a survey was conducted among trialists in Ireland. A total of 44 trialists responded to the survey, and information was collected about their experience in conducting clinical trials, the scale and nature of their most recently completed trial, and the details of specific barriers they encountered during the starting-up of the trial. In the second stage, nine semi-structured interviews were conducted with the awardees of 2018 Irish Health Research Board's Definitive Intervention Feasibility Award. These interviews facilitated a deeper exploration of issues and problems in conducting clinical trials in Ireland. RESULTS: This study identified several issues and bottlenecks in starting-up clinical trials in Ireland with contracts and ethical approval cited as the major issues. The data shows that site identification and activation was also problematic in some cases. Several respondents reported difficulties in accessing dedicated time for protocol development and believe that support in this area can be greatly beneficial. It was reported that availability of skilled staff members like statisticians and data managers was as an issue, especially for small trials. CONCLUSION: This study found that several factors impact trial initiation and progression in Ireland. Delays associated with obtaining contract and ethics approval are perceived as major barriers. Specialist supports in areas such as ethics and regulatory affairs and availability of specialised staff members in areas such as statistics and data management are key actions to enable enhanced clinical trial activity in Ireland.
引用
- Leddy L, Sukumar P, O'Sullivan L, et al. An investigation into the factors affecting investigator-initiated trial start-up in Ireland. Trials. 2020. PMID: 33228755. doi:10.1186/s13063-020-04893-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。